44 related articles for article (PubMed ID: 9816271)
21. Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer?
Camps C; Sirera R; Bremnes R; Blasco A; Sancho E; Bayo P; Safont MJ; Sánchez JJ; Tarón M; Rosell R
Lung Cancer; 2005 Dec; 50(3):339-46. PubMed ID: 16139926
[TBL] [Abstract][Full Text] [Related]
22. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
24. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma.
Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M
Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277
[TBL] [Abstract][Full Text] [Related]
25. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
26. Occurrence of ras mutations in human lung cancer. Minireview.
Vachtenheim J
Neoplasma; 1997; 44(3):145-9. PubMed ID: 9372854
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of ras oncogene activation in human lung cancer.
Rodenhuis S; Slebos RJ
Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
[TBL] [Abstract][Full Text] [Related]
28. ras oncogenes in human cancer: a review.
Bos JL
Cancer Res; 1989 Sep; 49(17):4682-9. PubMed ID: 2547513
[TBL] [Abstract][Full Text] [Related]
29. K-ras mutations in non-small-cell lung carcinoma: a review.
Aviel-Ronen S; Blackhall FH; Shepherd FA; Tsao MS
Clin Lung Cancer; 2006 Jul; 8(1):30-8. PubMed ID: 16870043
[TBL] [Abstract][Full Text] [Related]
30. K-ras role in lung cancer therapy.
Zhang Z; Wang Z
Minerva Chir; 2011 Jun; 66(3):251-68. PubMed ID: 21666562
[TBL] [Abstract][Full Text] [Related]
31. K-ras as a target for lung cancer therapy.
Adjei AA
J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S160-3. PubMed ID: 18520303
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer.
Jacobson DR; Fishman CL; Mills NE
Ann Oncol; 1995; 6 Suppl 3():S3-8. PubMed ID: 8616111
[TBL] [Abstract][Full Text] [Related]
33. [Research advances of K-ras mutation in the prognosis and targeted therapy of gastric cancer].
Huang Y; Wei J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):81-5. PubMed ID: 26899324
[TBL] [Abstract][Full Text] [Related]
34. Molecular staging of non-small cell lung cancer according to K-ras genotypes.
Rosell R; Monzó M; Pifarré A; Ariza A; Sánchez JJ; Moreno I; Maurel J; López MP; Abad A; de Anta JM
Clin Cancer Res; 1996 Jun; 2(6):1083-6. PubMed ID: 9816271
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
